FDA Orders Kyle Turley To Cease CBD Coronavirus Cure Claims

The United States Food and Drug Administration (FDA) has issued a warning letter to Kyle Turley’s NeuroXPF company regarding claims about cannabidiol (CBD) and COVID-19.

Since early March, Turley has made claims on his Twitter account that CBD can prevent and cure the coronavirus.

The FDA warning letter states that, following an investigation of Turley’s social media and the NeuroXP website, they determined that CBD products intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people were being offered for sale in the United States through the website, violating provisions of the Food, Drug & Cosmetic Act.

“Therefore, the FDA is taking urgent measures to protect consumers from certain products that, without approval or authorization by FDA, claim to mitigate, prevent, treat, diagnose, or cure COVID-19 in people,” states the letter. “As described below, you sell products that are intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people. We request that you take immediate action to cease the sale of such unapproved and unauthorized products…”

FDA noted that NeuroXPF would be added to a list of companies that have received warning letters from the Administration concerning their sale or distribution of COVID-19-related products.

Once the appropriate corrective actions have been taken by the company, FDA says that the list will be updated to indicate that the issue has been resolved.

In a tweet on Thursday, April 2, Turley partially walked-back previous statements, writing that cheap CBD brands products would not cure or prevent COVID-19.

Failure to comply with the violations cited in the letter, says FDA, could result in legal action, including seizure and injunction without limitation.